Related Experiment Videos
Antitumor effects of interferon
1Laboratory of Viral Oncology, Groupe de Laboratoires de L'Institut de Recherches Scientifiques sur le Cancer, Villejuif, France.
Abstract:
Both natural and recombinant interferons have shown definite antitumor activity in some patients with some malignancies. The history of the development of interferon as an antitumor agent is reviewed, with special attention to its use in mice bearing 'spontaneously' appearing tumors and in mice injected with tumorigenic viruses or transplantable tumor cells. Interferon can inhibit the growth of primary tumors as well as the development of metastases. These experimental results have provided some indications as to the probable optimal regimens of interferon administration in man. Although the mechanisms of interferon's antitumor activity are unknown, it seems likely that interferon can act directly on the tumor cells as well as on the tumor bearing host.
Insights
Interferon, a protein naturally produced by the body, demonstrates antitumor effects against various cancers. Research in mice suggests interferon therapy can inhibit tumor growth and metastasis, offering potential treatment strategies for human malignancies.
Area of Science:
- Immunology
- Oncology
- Virology
Background:
- Natural and recombinant interferons exhibit antitumor activity in certain malignancies.
- Interferon's historical development as an anticancer agent is reviewed.
- Previous studies explored interferon's efficacy in preclinical models.
Purpose of the Study:
- To review the development of interferon as an antitumor agent.
- To examine interferon's effects on primary tumors and metastases in experimental models.
- To provide insights into optimal interferon administration regimens for human use.
Main Methods:
- Review of historical data on interferon therapy.
- Preclinical studies using mice with spontaneous, virus-induced, or transplantable tumors.
- Analysis of interferon's impact on tumor growth and metastasis.
Main Results:
- Interferon demonstrated antitumor activity in preclinical models.
- Interferon inhibited the growth of primary tumors.
- Interferon also suppressed the development of metastases.
Conclusions:
- Experimental findings suggest potential optimal interferon administration regimens for humans.
- Interferon's antitumor mechanisms remain largely unknown.
- Interferon may exert direct effects on tumor cells and the tumor-bearing host.